Dong, S., Wei, C., Wang, X., Yang, X., Shen, W., Li, S., . . . Li, N. A retrospective multicenter study on the efficacy and safety of disitamab vedotin monotherapy versus combination with anti-PD-1 immunotherapy in advanced gastric cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationDong, Shuailei, et al. A Retrospective Multicenter Study on the Efficacy and Safety of Disitamab Vedotin Monotherapy Versus Combination with Anti-PD-1 Immunotherapy in Advanced Gastric Cancer. Nature Portfolio.
MLA (9th ed.) CitationDong, Shuailei, et al. A Retrospective Multicenter Study on the Efficacy and Safety of Disitamab Vedotin Monotherapy Versus Combination with Anti-PD-1 Immunotherapy in Advanced Gastric Cancer. Nature Portfolio.
Warning: These citations may not always be 100% accurate.